Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
Clinical trial NCT01456013 · UNKNOWN
Trial details
- NCT number
- NCT01456013
- Sponsor
- CardioRenal Systems, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2018-03-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.